Neurobiological fingerprints of negative symptoms in schizophrenia identified by connectome-based modeling
- PMID: 39815736
- DOI: 10.1111/pcn.13782
Neurobiological fingerprints of negative symptoms in schizophrenia identified by connectome-based modeling
Abstract
Aim: As a central component of schizophrenia psychopathology, negative symptoms result in detrimental effects on long-term functional prognosis. However, the neurobiological mechanism underlying negative symptoms remains poorly understood, which limits the development of novel treatment interventions. This study aimed to identify the specific neural fingerprints of negative symptoms in schizophrenia.
Methods: Based on resting-state functional connectivity data obtained in a large sample (n = 132) of first-episode drug-naïve schizophrenia patients (DN-FES), connectome-based predictive modeling (CPM) with cross-validation was applied to identify functional networks that predict the severity of negative symptoms. The generalizability of identified networks was then validated in an independent sample of n = 40 DN-FES.
Results: A connectivity pattern significantly driving the prediction of negative symptoms (ρ = 0.28, MSE = 81.04, P = 0.012) was identified within and between networks implicated in motivation (medial frontal, subcortical, sensorimotor), cognition (default mode, frontoparietal, medial frontal) and error processing (medial frontal and cerebellum). The identified networks also predicted negative symptoms in the independent validation sample (ρ = 0.37, P = 0.018). Importantly, the predictive model was symptom-specific and robust considering the potential effects of demographic characteristics and validation strategies.
Conclusions: Our study discovers and validates a comprehensive network model as the unique neural substrates of negative symptoms in schizophrenia, which provides a novel and comprehensive perspective to the development of target treatment strategies for negative symptoms.
Keywords: connectome‐based predictive modeling; negative symptom; neural fingerprint; resting‐state functional connectivity; schizophrenia.
© 2025 The Author(s). Psychiatry and Clinical Neurosciences © 2025 Japanese Society of Psychiatry and Neurology.
References
-
- Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet (London, England) 2016; 388: 86–97.
-
- Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990‐2019: A systematic analysis for the global burden of disease study 2019. Lancet Psychiatry 2022; 9: 137–150.
-
- Galderisi S, Mucci A, Buchanan RW, Arango C. Negative symptoms of schizophrenia: New developments and unanswered research questions. Lancet Psychiatry 2018; 5: 664–677.
-
- Bobes J, Arango C, Garcia‐Garcia M, Rejas J. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: Findings from the CLAMORS study. J. Clin. Psychiatry 2010; 71: 280–286.
-
- Rabinowitz J, Levine SZ, Garibaldi G, Bugarski‐Kirola D, Berardo CG, Kapur S. Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: Analysis of CATIE data. Schizophr. Res. 2012; 137: 147–150.
MeSH terms
Grants and funding
- 82120108014/National Natural Science Foundation of China
- 82071908/National Natural Science Foundation of China
- 81901705/National Natural Science Foundation of China
- 2021JDTD0002/Sichuan Science and Technology Program
- 2020YFS0116/Sichuan Science and Technology Program
- 2024NSFSC1773/Sichuan Science and Technology Program
- 2022-YF09-00062-SN/Chengdu Science and Technology Bureau
- 2022-GH03-00017-HZ/Chengdu Science and Technology Bureau
- 2021-I2M-C&T-A-022/CAMS Innovation Fund for Medical Sciences
- ZYGD23003/West China Hospital, Sichuan University
- 2023HXBH025/West China Hospital, Sichuan University
- 2023SCUH0058/Sichuan University
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous